Literature DB >> 21544576

Hormonal determinants and effect of ER22/23EK glucocorticoid receptor gene polymorphism on health status deterioration in the participants of the Mataró Ageing Study.

Mireia Mora1, Lidia Sánchez, Mateu Serra-Prat, Elisabet Palomera, Jesús Blanco, Gloria Aranda, Immaculada Falcón, Immaculada Cadenas, Xavier Boquet, Josep Oriola, Manuel Puig-Domingo.   

Abstract

The purpose of this study is to assess the potential relationships of circulating IGF-I, adrenal and gonadal steroids, and polymorphism ER22/23EK of the glucocorticoid receptor (GC-R) gene with nutritional, functional and cognitive deterioration in a group of elderly people living independently. This is a population-based prospective study with 313 individuals (160 women and 153 men, 76.7 ± 7 years) who participated. A physical exam, evaluation of functional capacity (Barthel scale), cognitive function (mini-mental state examination-MMSE), geriatric depression scale (GDS), mininutritional assessment (MNA-SF) and cardiometabolic status were performed at basal time point and at 2 years of follow-up. Biological measurements included cortisol, dehydroepiandrosterone (DHEA), DHEA sulphate, testosterone, estradiol, IGF-I and polymorphism ER22/23EK of the GC-R gene. Estradiol was associated with MNA-SF decrease over time (p < 0.01, adjusted for age and gender, beta = -0.17, p = 0.03). Weight loss was related to testosterone in men (8.6 vs 12.1 pg/ml in no losers; p = 0.03), and in women with GDS (13.0% with depression vs 3.3% with no depression; p = 0.05) and MMSE (22.2% with cognitive deterioration vs 4.8% with no cognitive deterioration; p = 0.049). Barthel decrease was associated with testosterone (p = 0.02, after adjusting for age and gender, beta = -0.520, p < 0.001), and SHBG (p < 0.01, adjusted for age and gender, beta = 0.18, p < 0.01). DHEA was associated with deterioration in the MMSE (p = 0.01, after adjusting for age, gender, GDS scale and academic status, beta = -0.26, p = 0.01). Frailty development was related only in men with testosterone levels at the beginning of the study (p = 0.017). ER22/23EK was found in 3% of the subjects and carriers had a lower prevalence of hypertension. Adrenal and gonadal steroids are associated to impairment of the ageing health condition in elderly individuals living independently in Spain. ER22/23EK polymorphism of the GC-R gene has a low prevalence in our population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544576      PMCID: PMC3337942          DOI: 10.1007/s11357-011-9255-z

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  31 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

3.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Int J Androl       Date:  2005-06

4.  Assessment of older people: self-maintaining and instrumental activities of daily living.

Authors:  M P Lawton; E M Brody
Journal:  Gerontologist       Date:  1969

5.  Hippocampal damage associated with prolonged glucocorticoid exposure in primates.

Authors:  R M Sapolsky; H Uno; C S Rebert; C E Finch
Journal:  J Neurosci       Date:  1990-09       Impact factor: 6.167

6.  Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study.

Authors:  E Barrett-Connor; D von Mühlen; G A Laughlin; A Kripke
Journal:  J Am Geriatr Soc       Date:  1999-06       Impact factor: 5.562

7.  Development and testing of a five-item version of the Geriatric Depression Scale.

Authors:  M T Hoyl; C A Alessi; J O Harker; K R Josephson; F M Pietruszka; M Koelfgen; J R Mervis; L J Fitten; L Z Rubenstein
Journal:  J Am Geriatr Soc       Date:  1999-07       Impact factor: 5.562

8.  Insulin-like growth factor-I and cognitive function in healthy older men.

Authors:  A Aleman; H J Verhaar; E H De Haan; W R De Vries; M M Samson; M L Drent; E A Van der Veen; H P Koppeschaar
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

9.  Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study.

Authors:  E Barrett-Connor; D G Von Mühlen; D Kritz-Silverstein
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

10.  Effects of testosterone supplementation in the aging male.

Authors:  J S Tenover
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

View more
  3 in total

Review 1.  Low Testosterone Level and Risk of Alzheimer's Disease in the Elderly Men: a Systematic Review and Meta-Analysis.

Authors:  Wenshan Lv; Na Du; Ying Liu; Xinyi Fan; Yunyang Wang; Xiujuan Jia; Xu Hou; Bin Wang
Journal:  Mol Neurobiol       Date:  2015-07-08       Impact factor: 5.590

2.  Obestatin is associated to muscle strength, functional capacity and cognitive status in old women.

Authors:  Mireia Mora; María Luisa Granada; Elisabet Palomera; Mateu Serra-Prat; Manel Puig-Domingo
Journal:  Age (Dordr)       Date:  2013-04-23

3.  Dysregulation of the hypothalamic pituitary adrenal (HPA) axis and cognitive capability at older ages: individual participant meta-analysis of five cohorts.

Authors:  Michael Gardner; Stafford Lightman; Diana Kuh; Hannie Comijs; Dorly Deeg; John Gallacher; Marie-Claude Geoffroy; Mika Kivimaki; Meena Kumari; Chris Power; Rebecca Hardy; Marcus Richards; Yoav Ben-Shlomo
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.